OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gastric adenocarcinoma
Jaffer A. Ajani, Jeeyun Lee, Takeshi Sano, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 474
Jaffer A. Ajani, Jeeyun Lee, Takeshi Sano, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 474
Showing 1-25 of 474 citing articles:
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian, Kohei Shitara, Markus Moehler, et al.
The Lancet (2021) Vol. 398, Iss. 10294, pp. 27-40
Open Access | Times Cited: 2008
Yelena Y. Janjigian, Kohei Shitara, Markus Moehler, et al.
The Lancet (2021) Vol. 398, Iss. 10294, pp. 27-40
Open Access | Times Cited: 2008
Epstein-Barr virus-associated gastric adenocarcinoma
Н. В. Данилова, П.Г. Мальков, N A Oleynikova, et al.
Russian Journal of Archive of Pathology (2019) Vol. 81, Iss. 3, pp. 74-74
Closed Access | Times Cited: 521
Н. В. Данилова, П.Г. Мальков, N A Oleynikova, et al.
Russian Journal of Archive of Pathology (2019) Vol. 81, Iss. 3, pp. 74-74
Closed Access | Times Cited: 521
Fibroblast growth factor receptors as treatment targets in clinical oncology
Masaru Katoh
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 105-122
Closed Access | Times Cited: 300
Masaru Katoh
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 105-122
Closed Access | Times Cited: 300
Current status of immune checkpoint inhibitors for gastric cancer
Koji Kono, Shotaro Nakajima, Kosaku Mimura
Gastric Cancer (2020) Vol. 23, Iss. 4, pp. 565-578
Open Access | Times Cited: 191
Koji Kono, Shotaro Nakajima, Kosaku Mimura
Gastric Cancer (2020) Vol. 23, Iss. 4, pp. 565-578
Open Access | Times Cited: 191
Gallbladder cancer
Juan Carlos Roa, Patricia García, Vinay K. Kapoor, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 190
Juan Carlos Roa, Patricia García, Vinay K. Kapoor, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 190
Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
Zirui Zhao, Haohan Liu, Xingyu Zhou, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 174
Zirui Zhao, Haohan Liu, Xingyu Zhou, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 174
The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies
Sara K. Daniel, Yongwoo David Seo, Venu G. Pillarisetty
Seminars in Cancer Biology (2019) Vol. 65, pp. 176-188
Closed Access | Times Cited: 173
Sara K. Daniel, Yongwoo David Seo, Venu G. Pillarisetty
Seminars in Cancer Biology (2019) Vol. 65, pp. 176-188
Closed Access | Times Cited: 173
Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review)
Masaru Katoh
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 172
Masaru Katoh
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 172
Gastrointestinal cancers in China, the USA, and Europe
Yumo Xie, Lishuo Shi, Xiaosheng He, et al.
Gastroenterology report (2021) Vol. 9, Iss. 2, pp. 91-104
Open Access | Times Cited: 171
Yumo Xie, Lishuo Shi, Xiaosheng He, et al.
Gastroenterology report (2021) Vol. 9, Iss. 2, pp. 91-104
Open Access | Times Cited: 171
Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma
Run Lin, Hui Zhang, Yujie Yuan, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 4, pp. 479-492
Closed Access | Times Cited: 170
Run Lin, Hui Zhang, Yujie Yuan, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 4, pp. 479-492
Closed Access | Times Cited: 170
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Mihnea P. Dragomir, Scott Kopetz, Jaffer A. Ajani, et al.
Gut (2020) Vol. 69, Iss. 4, pp. 748-763
Closed Access | Times Cited: 169
Mihnea P. Dragomir, Scott Kopetz, Jaffer A. Ajani, et al.
Gut (2020) Vol. 69, Iss. 4, pp. 748-763
Closed Access | Times Cited: 169
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
PPAR-α Modulators as Current and Potential Cancer Treatments
Yan Tan, Mina Wang, Yang Ke, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 110
Yan Tan, Mina Wang, Yang Ke, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 110
The immune microenvironment in gastric adenocarcinoma
Yana Zavros, Juanita L. Merchant
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 7, pp. 451-467
Open Access | Times Cited: 93
Yana Zavros, Juanita L. Merchant
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 7, pp. 451-467
Open Access | Times Cited: 93
Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
Xin Jin, Zhaorui Liu, Dongxiao Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Xin Jin, Zhaorui Liu, Dongxiao Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
USP14: Structure, Function, and Target Inhibition
Feng Wang, Shuo Ning, Beiming Yu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 74
Feng Wang, Shuo Ning, Beiming Yu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 74
Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression
Min Deng, Long Zhang, Wenying Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 53
Min Deng, Long Zhang, Wenying Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 53
Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells
Tianyu Cao, Wenyao Zhang, Qi Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2288-2304.e27
Closed Access | Times Cited: 52
Tianyu Cao, Wenyao Zhang, Qi Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2288-2304.e27
Closed Access | Times Cited: 52
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
Lin Shen, Yanqiao Zhang, Ziyu Li, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 4
Lin Shen, Yanqiao Zhang, Ziyu Li, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 4
Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
Ruiping Wang, Shumei Song, Kazuto Harada, et al.
Gut (2019) Vol. 69, Iss. 1, pp. 18-31
Open Access | Times Cited: 124
Ruiping Wang, Shumei Song, Kazuto Harada, et al.
Gut (2019) Vol. 69, Iss. 1, pp. 18-31
Open Access | Times Cited: 124
FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics
Li Li, Zhu Zu-an, Yanchao Zhao, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 121
Li Li, Zhu Zu-an, Yanchao Zhao, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 121
The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis
Quan Zhou, Xiongyan Wu, Xiaofeng Wang, et al.
Oncogene (2019) Vol. 39, Iss. 7, pp. 1414-1428
Open Access | Times Cited: 109
Quan Zhou, Xiongyan Wu, Xiaofeng Wang, et al.
Oncogene (2019) Vol. 39, Iss. 7, pp. 1414-1428
Open Access | Times Cited: 109
Changes of the Gastric Mucosal Microbiome Associated With Histological Stages of Gastric Carcinogenesis
Zikai Wang, Xuefeng Gao, Ranran Zeng, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 105
Zikai Wang, Xuefeng Gao, Ranran Zeng, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 105
Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop
Xiang Xia, Shuchang Wang, Bo Ni, et al.
Oncogene (2020) Vol. 39, Iss. 39, pp. 6231-6244
Closed Access | Times Cited: 105
Xiang Xia, Shuchang Wang, Bo Ni, et al.
Oncogene (2020) Vol. 39, Iss. 39, pp. 6231-6244
Closed Access | Times Cited: 105
SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating EMT
Jundong Yang, Lin Ma, Zhen Zhu
Journal of Chemotherapy (2019) Vol. 31, Iss. 7-8, pp. 408-418
Closed Access | Times Cited: 90
Jundong Yang, Lin Ma, Zhen Zhu
Journal of Chemotherapy (2019) Vol. 31, Iss. 7-8, pp. 408-418
Closed Access | Times Cited: 90
